Charlottesville, VA, United States of America

Ryan E Feaver

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ryan E Feaver: Innovator in In Vitro Models

Introduction

Ryan E Feaver is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical research, particularly in developing in vitro models that mimic physiological and pathological conditions. With a total of 5 patents to his name, Feaver's work is paving the way for advancements in drug testing and disease modeling.

Latest Patents

One of Ryan E Feaver's latest patents focuses on an in vitro model for pathological or physiologic conditions. This invention relates to methods for mimicking in vivo conditions by applying shear forces to specific cell types plated on surfaces within cell culture containers. The patent also describes methods for testing drugs or compounds in these innovative systems, showcasing the potential for improved therapeutic development.

Career Highlights

Feaver is currently associated with Hemoshear, LLC, where he continues to push the boundaries of biomedical research. His work is instrumental in creating more accurate models for studying diseases, which can lead to better treatment options for patients. His innovative approaches have garnered attention in the scientific community, further establishing his reputation as a leading inventor in his field.

Collaborations

Ryan E Feaver collaborates with talented professionals such as Brett R Blackman and Ajit Dash. These partnerships enhance the research and development efforts at Hemoshear, LLC, contributing to the advancement of their innovative projects.

Conclusion

In summary, Ryan E Feaver is a distinguished inventor whose work in developing in vitro models is making a significant impact in biomedical research. His contributions are vital for the future of drug testing and disease understanding, and his ongoing efforts at Hemoshear, LLC, continue to inspire innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…